중동 및 아프리카 유세포 분석 시장 – 2030년까지의 산업 동향 및 예측

중동 및 아프리카 유세포 분석 시장 분석 및 통찰력

중동 및 아프리카 유세포 분석 시장은 만성 질환의 유병률 증가, 유세포 분석 시장에서 신기술에 대한 수요 증가(수요 증가), 연구 개발 투자 증가(시장 성장으로 이어짐)와 같은 요인에 의해 주도됩니다. 현재 선진국과 신흥국에서 의료비 지출이 증가하여 제조업체가 새롭고 혁신적인 유세포 분석 시장을 개발할 수 있는 경쟁 우위를 확보할 것으로 예상됩니다. 그러나 유세포 분석 장비의 높은 비용은 중동 및 아프리카 유세포 분석 시장 성장을 억제할 것으로 예상됩니다.

중동 및 아프리카 유세포 분석 시장은 2023년부터 2030년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2023년부터 2030년까지의 예측 기간 동안 6.9%의 CAGR로 성장하고 있으며 2022년 5,673만 달러에서 2030년까지 9,586만 달러에 도달할 것으로 예상한다고 분석합니다.

중동 및 아프리카 유세포 분석 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 현지 시장 참여자의 영향, 새로운 수익 창출, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 당사에 문의하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다. 다양한 지역의 개발도상국에 있는 소매점의 확장성과 사업 확장, 기계 및 의약품의 안전한 유통을 위한 공급업체와의 파트너십은 예측 기간 동안 시장 수요를 촉진한 주요 원동력입니다.

Market Definition

Flow cytometry is a key process for screening cells from a heterologous cell mixture used in cell sorting, counting, protein regeneration, and engineering. The analysis of cell surface and intracellular molecule expression, the characterization and definition of various cell types in a heterogeneous cell population, the evaluation of the purity of isolated subpopulations, and the measurement of cell size and volume are all common uses for flow cytometry. It enables the simultaneous examination of multiple parameters for a single cell. A flow cytometer uses lasers to produce light, which is subsequently dispersed by the sample's cells, recorded by detectors, and converted into signals for analysis and measurement.

The increasing innovations and technologies, rising number of players in the market, and novel product launches are also propelling the growth of the Middle East and Africa flows cytometry market.

Middle East and Africa Flow Cytometry Market Dynamics

Drivers

• Rising prevalence of chronic diseases

These increasing prevalence and incidences of chronic diseases are likely to drive market growth by focusing on cytometry devices. The increasing incidences of diseases lead to an increase in the Middle East and Africa market as many companies are investing in research and development. This resulted in the enormous lead in demand for advancements to diagnose the disease through quick and accurate techniques.

For instance,

• In January 2021, according to a World Health Organization report, cancer became the major cause of death in 2020, with 10 million in approximation, where often cases were of breast cancer (2.26 million), lung (2.21 million), colon and rectum (1.93 million); prostate (1.41 million), skin (1.20 million) and stomach (1.09 million)

Therefore, this is raising the demand for the Middle East and Africa flow cytometry market.

• Increasing application of cytometry instruments

Technological developments in cytometry instruments are rising by combining several new techniques to provide high resolution and sensitivity to quantify new entities of cells.

The immunophenotypic analysis is important not only for the initial diagnosis and categorization of acute leukemia, chronic lymphoproliferative disorders, and malignant lymphomas but also for their treatment. Flow cytometry can be used as a sensitive assay to track patients' improvement after chemotherapy or transplantation and detect minimal residual illness (MRD).

For instance,

• In January 2022, Becton, Dickinson and Company, a Middle East and Africa medical technology company, announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published the new BD innovation in flow cytometry that adds fluorescence imaging and image-based deaccessioning to sort individual cells at exceptionally high speed, based on the visual details of each cell rather than the type or quantity of biomarkers present. The novel method has the potential to revolutionize immunology, cell biology, and genomics research, as well as enable the development of new cell-based therapeutics

 Thus, this is expected to act as a driver for the growth of the Middle East and Africa flow cytometry market.

Opportunities

• Strategic initiatives by market players

With the increasing burden of infectious diseases such as COVID-19 and chronic diseases such as cancer, the demand for advanced research in the region is high—the dramatic rise in the quality of research worldwide.

• In August 2021, BD launched its new Benchtop cell analyzer, "BD FACSymphony A1 Cell Analyzer," which brings sophisticated flow cytometry capabilities to laboratories of all sizes. This fluorescence-activated cell sorter (FACS) technology enables good isolation and provides access to various flow cytometry experiments in their laboratories. This improved their revenue over the segment
• In June 2019, Agilent Technologies Inc. acquired ACEA Biosciences and launched their new product, "Agilent NovoCyte Advanteon Flow Cytometer," at the 34th congress of the International Society for Advancement of Cytometry, CYTO 2019 congress. This new product enabled the company to mark its footprint in the flow cytometry market

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the Middle East and Africa flows cytometry market in the forecast period of 2023-2030.

Restraints/Challenges

• High cost of flow cytometry instruments

Flow cytometers come in a variety of shapes and sizes, although benchtop instruments are the most common. They offer optimal data analysis, the convenience of use, and upgrades and options for various systems, all of which are intended to solve customized separations, cell/particle sorting, exploratory cell analysis, and other issues. All flow cytometers feature three common components – fluids, optics, and electronics/informatics.

Flow cytometers are very expensive especially considering the cost associated with repair and maintenance.

• Lack of skilled professionals

The lack or shortage of skilled expertise would restrain the pace of recovery and growth in one place. Often the people who are unemployed in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to a lack of expertise.

Flow cytometry is a sophisticated instrument that can concurrently measure the size and granularity of a single cell as it moves through a measurement device in suspension. Cell sorters and flow cytometry analyzers can be operated by persons who have been educated in safety procedures. Hence, this is expected to impede the market growth.

COVID-19 Impact on the Middle East and Africa Flow Cytometry Market

COVID-19 has positively affected the market due to disease diagnosis and research purposes, which raises the demand for flow cytometry during this period.

Recent Development

• In January 2022, Sony Biotechnology, Inc. presented a novel closed cell isolation system CGX10 for use in GMP-compliant cell sorting applications. With the initiative, new growth opportunities were hoped for the company. Such advances in technology will lead to cost-effectiveness, greater accuracy and portability and are likely to create future growth opportunities.

Middle East and Africa Flow Cytometry Market Scope

Middle East and Africa flow cytometry market is segmented into product, technology, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Product

• Reagents and consumables
• Flow cytometry instruments
• Accessories
• Services
• Software

On the basis of product, the Middle East and Africa flow cytometry market is segmented into flow cytometry instruments, reagents and consumables, software, accessories, and services.

Technology

• Cell-based flow cytometry
• Bead-based flow cytometry

On the basis of technology, the Middle East and Africa flow cytometry market is segmented into cell-based flow cytometry and bead-based flow cytometry.

Application

• Research applications
• Clinical applications
• Industrial applications

On the basis of application, the Middle East and Africa flow cytometry market is segmented into research applications, clinical applications, and industrial applications.

End User

• Pharmaceuticals & biotechnology companies
• Academic & Research institutes
• Hospitals
• Clinical testing laboratories
• Blood bank
• Others

On the basis of end users, the Middle East and Africa flow cytometry market is segmented into academic & research institutes, hospitals, pharmaceutical & biotechnology companies, clinical testing laboratories, blood bank, and others.

Distribution Channel

• Retail sales
• Direct tenders

On the basis of distribution channel, the Middle East and Africa flow cytometry market is segmented into retail sales and direct tenders.

Middle East and Africa Flow Cytometry Market Regional Analysis/Insights

The Middle East and Africa flow cytometry market is analyzed, and market size insights and trends are provided by country, product, technology, application, end user, and distribution channel, as referenced above.

South Africa is the major dominating country in the market due to rising strategic initiatives by key market players to enhance business and rising awareness among the population in the country. And they are dominating the flow cytometry market in terms of market share and market revenue and will continue to flourish dominance during the forecast period.

The country section of the report also provides individual market impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of Middle East and Africa brands and the challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Middle East and Africa Flow Cytometry Market Share Analysis

Middle East and Africa flow cytometry market competitive landscape provides details about the competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the company's focus on the Middle East and Africa flow cytometry market.

Some of the major players operating in the Middle East and Africa flow cytometry market are Thermo Fisher Scientific Inc., BD, Bio-Rad Laboratories, Inc., Sysmex Corporation, Beckman Coulter, Inc. (A subsidiary of Danaher Corporation), bioMérieux SA, Merck KGaA, Enzo Biochem Inc., Takara Bio Inc., Sartorius AG, Q2 Solutions (a Subsidiary of IQVIA), Elabscience Biotechnology Inc., ORFLO Technologies, among others.

SKU-28393